Endobronchial Aspergillosis Presenting as an Isolated Airway Lesion in an Immunocompromised Patient

ABSTRACT Endobronchial aspergillosis (EBA) is an uncommon manifestation of Aspergillus airway disease characterized by fungal involvement of the tracheobronchial lumen. It may present with non‐specific respiratory symptoms, including dyspnea, cough and hemoptysis, and can mimic endoluminal airway tumours. Predisposing factors include immunosuppressive conditions such as corticosteroid therapy, malignancy, chemotherapy and neutropenia. Definitive diagnosis relies on bronchoscopic evaluation with histopathological confirmation. Due to its rarity, evidence regarding optimal management remains limited. This case emphasizes that isolated airway Aspergillus infection may occur without parenchymal lung involvement and may be associated with a rapidly fatal clinical course despite prompt antifungal therapy.

Authors

Institutions

Publication Details

Journal
Respirology Case Reports
Published
2026-09-01
DOI
https://doi.org/10.1002/rcr2.70701
Primary Topic
Antifungal resistance and susceptibility
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Endobronchial Aspergillosis Presenting as an Isolated Airway Lesion in an Immunocompromised Patient

Amir Morteza Soleimani, Fatemeh Sadat Hosseini Khajouei, Haniyeh GhanbarAliAkhavan, Mohsen Sadeghi
Respirology Case Reports
Antifungal resistance and susceptibility
article

Endobronchial Aspergillosis Presenting as an Isolated Airway Lesion in an Immunocompromised Patient

Amir Morteza Soleimani, Fatemeh Sadat Hosseini Khajouei, Haniyeh GhanbarAliAkhavan, Mohsen Sadeghi
article en

Abstract

ABSTRACT Endobronchial aspergillosis (EBA) is an uncommon manifestation of Aspergillus airway disease characterized by fungal involvement of the tracheobronchial lumen. It may present with non‐specific respiratory symptoms, including dyspnea, cough and hemoptysis, and can mimic endoluminal airway tumours. Predisposing factors include immunosuppressive conditions such as corticosteroid therapy, malignancy, chemotherapy and neutropenia. Definitive diagnosis relies on bronchoscopic evaluation with histopathological confirmation. Due to its rarity, evidence regarding optimal management remains limited. This case emphasizes that isolated airway Aspergillus infection may occur without parenchymal lung involvement and may be associated with a rapidly fatal clinical course despite prompt antifungal therapy.

Respirology Case ReportsVol. 14(9)
Arak University of Medical Sciences (IR), Guilan University of Medical Sciences (IR), Masih Daneshvari Hospital (IR)
Arak University of Medical Sciences
Good health and well-being
Openalex Percentile: Top 11%
Antifungal resistance and susceptibility
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Endobronchial Aspergillosis Presenting as an Isolated Airway Lesion in an Immunocompromised Patient — Amir Morteza Soleimani, Fatemeh Sadat Hosseini Khajouei, et al. · Respirology Case Reports (2026) | TGRS Research Map | TGRS